title: Excessive antibiotic use in men with prostatitis.
abstract: BACKGROUND
  Prostatitis accounts for 2 million outpatient visits annually. The majority of prostatitis cases fit the definition of chronic pelvic pain syndrome, for which routine antibiotic use is not indicated.
  
  
  METHODS
  Inpatient, outpatient, and pharmacy datasets from the Veterans Health Administration were used to quantify the magnitude of antibiotic use attributable to chronic pelvic pain syndrome. Specifically, men with a diagnosis of infectious/acute prostatitis or a urinary tract infection were excluded, and the remaining men with a diagnosis of prostatitis were defined as having chronic pelvic pain syndrome.
  
  
  RESULTS
  The annual prevalence of chronic pelvic pain syndrome was 0.5%. Prescriptions for fluoroquinolone antibiotics were filled in 49% of men with a diagnosis of chronic pelvic pain syndrome compared with 5% in men without chronic pelvic pain syndrome. Men with chronic pelvic pain syndrome were more than 7 times more likely to receive a fluoroquinolone prescription independently of age, race/ethnicity, and comorbid conditions. Increased use of other antibiotics also was observed. High use was similar in men with either infectious/acute prostatitis or chronic pelvic pain syndrome.
  
  
  CONCLUSIONS
  Despite evidence that antibiotics are not effective in the majority of men with chronic pelvic pain syndrome, they were prescribed in 69% of men with this diagnosis. Some increased use is probably due to uncontrolled confounding by comorbid conditions or inaccurate diagnostic coding. However, a 7-fold higher rate of fluoroquinolone usage suggests that strategies to reduce unnecessary antibiotic use in men with prostatitis are warranted.
authors.affiliation: Center for Chronic Disease Outcomes Research, Veterans Affairs Medical Center, Minneapolis, MN 55417, USA.
authors.forename: Brent C
authors.initials: BC
authors.lastname: Taylor
authors.forename: Siamak
authors.initials: S
authors.lastname: Noorbaloochi
authors.forename: Mary
authors.initials: M
authors.lastname: McNaughton-Collins
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Saigal
authors.forename: Min-Woong
authors.initials: MW
authors.lastname: Sohn
authors.forename: Michel A
authors.initials: MA
authors.lastname: Pontari
authors.forename: Mark S
authors.initials: MS
authors.lastname: Litwin
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Wilt
mesh_terms: D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004363:Drug Utilization; D006801:Humans; D008297:Male; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents